These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20407894)

  • 41. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
    Leaw SJ; Yen CJ; Huang WT; Chen TY; Su WC; Tsao CJ
    Ann Hematol; 2004 May; 83(5):270-5. PubMed ID: 15060745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma.
    Cheng AL; Hsiung CA; Su IJ; Chen PJ; Chang MC; Tsao CJ; Kao WY; Uen WC; Hsu CH; Tien HF; Chao TY; Chen LT; Whang-Peng J;
    Hepatology; 2003 Jun; 37(6):1320-8. PubMed ID: 12774010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations.
    Alexopoulou A; Theodorou M; Dourakis SP; Karayiannis P; Sagkana E; Papanikolopoulos K; Archimandritis AJ
    J Viral Hepat; 2006 Sep; 13(9):591-6. PubMed ID: 16907845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Reactivation of hepatitis B infection due to glucocorticoids].
    Ramsoekh D; Metselaar HJ; de Man RA
    Ned Tijdschr Geneeskd; 2011; 155(50):A3710. PubMed ID: 22186363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of hepatitis B virus reactivation under rituximab therapy.
    Tsutsumi Y; Yamamoto Y; Tanaka J; Asaka M; Imamura M; Masauzi N
    Immunotherapy; 2009 Nov; 1(6):1053-61. PubMed ID: 20635919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Reactivation of hepatitis B virus in patients with hematological neoplasms].
    Takkenberg RB; Zaaijer HL; ten Cate DF; Biemond BJ; Jansen PL; Reesink HW
    Ned Tijdschr Geneeskd; 2009 May; 153(19):926-31. PubMed ID: 19489299
    [No Abstract]   [Full Text] [Related]  

  • 48. Kinetics of hepatitis B virus reactivation after chemotherapy: more questions than answers.
    Liu CJ; Kao JH; Chen DS
    Gastroenterology; 2006 Nov; 131(5):1656; author reply 1656-7. PubMed ID: 17101335
    [No Abstract]   [Full Text] [Related]  

  • 49. Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab.
    Hernández JA; Diloy R; Salat D; del Río N; Martínez X; Castellví JM
    Haematologica; 2003 Jun; 88(6):ECR22. PubMed ID: 12801855
    [No Abstract]   [Full Text] [Related]  

  • 50. Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment?
    Garcia-Rodriguez MJ; Canales MA; Hernandez-Maraver D; Hernandez-Navarro F
    Am J Hematol; 2008 Aug; 83(8):673-5. PubMed ID: 18528824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.
    Koo YX; Tan DS; Tan BH; Quek R; Tao M; Lim ST
    J Clin Oncol; 2009 May; 27(15):2570-1; author reply 2571-2. PubMed ID: 19364951
    [No Abstract]   [Full Text] [Related]  

  • 52. Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
    Schnepf N; Sellier P; Bendenoun M; Zini JM; Sanson-le Pors MJ; Mazeron MC
    J Clin Virol; 2007 May; 39(1):48-50. PubMed ID: 17368969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rituximab-associated infections.
    Gea-Banacloche JC
    Semin Hematol; 2010 Apr; 47(2):187-98. PubMed ID: 20350666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From a medical mistake to a clinical warning: the case of HBV mutant virus reactivation in haematological patients.
    Zoppoli G; Bruzzone B; Caligiuri P; Picciotto A; Balleari E; Bruzzone A; Icardi G; Ghio R
    Br J Haematol; 2009 Mar; 144(6):969-70. PubMed ID: 19120363
    [No Abstract]   [Full Text] [Related]  

  • 55. Severe hepatitis B virus reactivation related to ibrutinib monotherapy.
    Herishanu Y; Katchman H; Polliack A
    Ann Hematol; 2017 Apr; 96(4):689-690. PubMed ID: 28058492
    [No Abstract]   [Full Text] [Related]  

  • 56. Antiviral treatment including entecavir plus tenofovir disoproxil fumarate for HBV reactivation following a rituximab-based regimen.
    Rago A; Lichtner M; Mecarocci S; Marocco R; Cenfra N; Belvisi V; Del Borgo C; Cimino G; Mastroianni CM
    Antivir Ther; 2010; 15(6):929-32. PubMed ID: 20834107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection.
    Ahmed A; Keeffe EB
    Am J Gastroenterol; 1999 Jan; 94(1):249-51. PubMed ID: 9934765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hepatitis B associated membraneous glomerulonephritis: healing following drug-induced reactivation of hepatitis].
    Tönz O; Ramelli GP; Gebbers JO
    Helv Paediatr Acta; 1989 Jun; 43(5-6):539-47. PubMed ID: 2745148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis B virus-related liver disease in isolated anti-hepatitis B-core positive lymphoma patients receiving chemo- or chemo-immune therapy.
    Targhetta C; Cabras MG; Mamusa AM; Mascia G; Angelucci E
    Haematologica; 2008 Jun; 93(6):951-2. PubMed ID: 18515881
    [No Abstract]   [Full Text] [Related]  

  • 60. Reactivation of hepatitis B virus after rituximab-containing treatment in patients with CD20-positive B-cell lymphoma.
    Matsue K; Kimura S; Takanashi Y; Iwama K; Fujiwara H; Yamakura M; Takeuchi M
    Cancer; 2010 Oct; 116(20):4769-76. PubMed ID: 20597091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.